• Home
  • Emily’s Story
  • About Us
    • About Emily’s Entourage
    • Our Impact
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      • Research Inquiries
      • Research Resources
  • Events
    • Events & Activities
  • Press & Media
    • EE in the News
    • Press Releases
    • Videos
  • Take action
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate
DONATE
  • Home
  • Emily’s Story
  • About Us
    • About Emily’s Entourage
    • Our Impact
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      • Research Inquiries
      • Research Resources
  • Events
    • Events & Activities
  • Press & Media
    • EE in the News
    • Press Releases
    • Videos
  • Take action
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate

02 Feb 2012

Exciting new CF drug approval!

Hi all,

We have some HUGE news to share with you that all of us at Emily’s Entourage are extremely excited about. Early this week, it was announced that the FDA approved a new drug, Kalydeco, which is the FIRST EVER drug to correct the underlying genetic problem in Cystic Fibrosis (CF). However, the drug will only help 4% of the CF population who have a certain genetic mutation (G551D). Unfortunately, the remaining 96% of people living with CF, including Emily, are still waiting for their life-saving treatment.

With this enormous news, we are reminded why all of our fundraising efforts are SO important. The money we raise funds life-altering research like this. This amazing discovery shows us that we are SO close, but we are not there yet. We must keep pushing and keep vigorously fundraising so Emily and everyone else with CF can benefit from a life-changing treatment too. You can help by making a donation and continuing to spread the Emily’s Entourage message.

From us all of at Emily’s Entourage, thank you for your continued support!

-Emily’s Entourage

 

Read the CFF press release: https://www.cff.org/News/News-Archive/2012/FDA-Approves-Kalydeco-(VX-770)-%E2%80%94-First-Drug-That-Targets-the-Underlying-Cause-of-Cystic-Fibrosis/

Share Post: facebook-share linked-share twitter-share
Emily’s Entourage presents a (hefty) check to the CFF!
Where in the World is Emily’s Entourage?
The opinions stated by our guest contributors reflect the experiences and thoughts of the author alone. Our publication of these pieces does not reflect Emily’s Entourage’s endorsement or suggest a position on those opinions. The content on this site is for informational or educational purposes only and does not substitute professional medical advice or consultations with healthcare professionals.
  • Emily's Entourage Nonprofit Overview and Reviews on GreatNonprofits
    Volunteer. Donate. Review.
  • Home
  • About Emily’s Entourage
  • Careers
  • Contact Us
  • Donate
Sign Up for Updates >>

Emily’s Entourage
PO Box 71
Merion Station, PA 19066

Tax ID #45-3768161

Emily's Entourage
Website Managed By: Strategic Websites
  • Home
  • Emily’s Story
  • About Us
    ▼
    • About Emily’s Entourage
    • Our Impact
      ▼
      • 2022-2023 Impact Report
      • 2021 Impact Report
      • 2020 Impact Report
      • 2019 Impact Report
    • About Cystic Fibrosis
    • Meet Our Leadership
      ▼
      • Scientific Advisory Board
      • Board of Directors
      • Leadership Team
    • Partner Organizations
  • Research
    ▼
    • Areas of Focus
    • Awarded Grants
    • Funding Opportunities
      ▼
      • Venture Philanthropy Investments
      • Collaborative Grants
      • Translational Grants
    • CF Clinical Trial Connect
    • Clinical Trial Matchmaking Program
    • The Final 10% Survey
    • Publications
    • For Researchers
      ▼
      • Research Inquiries
      • Research Resources
  • Events
    ▼
    • Events & Activities
  • Press & Media
    ▼
    • EE in the News
    • Press Releases
    • Videos
  • Take action
    ▼
    • Donate
    • Get Involved
    • Join CF Clinical Trial Connect
    • Shop EE
    • Sign Up for Updates
  • Blog
  • Contact
  • Donate
English
Español Português Português do Brasil עִבְרִית Français Français du Canada Italiano Türkçe Svenska Deutsch